No association between SOD2 Val16Ala polymorphism and breast cancer susceptibility: a meta-analysis based on 9,710 cases and 11,041 controls

By Ma Xiangyu  

Breast Cancer Research and Treatment, Vol. 122, Iss. 2, 2010-07 ,pp. : 509-514

Springer Publishing Company

Access to resources Recommend Favorite

Possible risk modifications in the association between MnSOD Ala-9Val polymorphism and breast cancer risk: subgroup analysis and evidence-based sample size calculation for a future trial

By Chen Yun  

Breast Cancer Research and Treatment, Vol. 125, Iss. 2, 2011-01 ,pp. : 495-504

Springer Publishing Company

Access to resources Recommend Favorite

No association between CYP1B1 Val432Leu polymorphism and breast cancer risk: a meta-analysis involving 40,303 subjects

By Yao Lei  

Breast Cancer Research and Treatment, Vol. 122, Iss. 1, 2010-07 ,pp. : 237-242

Springer Publishing Company

Access to resources Recommend Favorite

Lack of significant association between CYP1A1 T3801C polymorphism and breast cancer risk: a meta-analysis involving 25,087 subjects

By Yao Lei  

Breast Cancer Research and Treatment, Vol. 122, Iss. 2, 2010-07 ,pp. : 503-507

Springer Publishing Company

Access to resources Recommend Favorite

Lack of an association between a functional polymorphism in the interleukin-6 gene promoter and breast cancer risk: a meta-analysis involving 25,703 subjects

By Yu Ke-Da  

Breast Cancer Research and Treatment, Vol. 122, Iss. 2, 2010-07 ,pp. : 483-488

Springer Publishing Company

Access to resources Recommend Favorite